These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2046079)

  • 1. Safety and efficacy of ethynodiol diacetate, 1 mg, plus ethinyl estradiol, 35 micrograms. A phase IV trial. Introduction.
    Friedman AJ
    J Reprod Med; 1991 Apr; 36(4 Suppl):323-4. PubMed ID: 2046079
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms, with an emphasis on contraceptive efficacy. A phase IV trial.
    Friedman AJ; Wheeler J
    J Reprod Med; 1991 Apr; 36(4 Suppl):328-33. PubMed ID: 2046081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexion changes in oral contraceptive users. Results from a phase IV multicenter trial evaluating the safety and efficacy of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms.
    Wheeler JM; Malinak LR
    J Reprod Med; 1991 Apr; 36(4 Suppl):340-4. PubMed ID: 2046083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further investigations concerning bisecurin, a peroral contraceptive of low hormonal contents.
    Bencsik A
    Ther Hung; 1973; 21(2):79-81. PubMed ID: 4792882
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aspects of hormonal therapy of climacteric cardiopathy associated with ischemic heart disease].
    Kretova NE; Smirnova AA
    Ter Arkh; 1979; 51(8):73-7. PubMed ID: 505308
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experiences with the long-term use of the oral low-dosage contraceptive Bisecurin].
    Marjanović M; Berić BM
    Med Pregl; 1975; 28(9-10):425-7. PubMed ID: 1186615
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biological activities of 3 different types of ethynodiol diacetate-ethynyl estradiol combinations (author's transl)].
    Higashiyama S
    Nihon Funin Gakkai Zasshi; 1978 Oct; 23(4):414-20. PubMed ID: 710724
    [No Abstract]   [Full Text] [Related]  

  • 8. Epistaxis secondary to oral contraceptive.
    Man A; Segal S
    Acta Otolaryngol; 1981; 92(3-4):383-4. PubMed ID: 7324906
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
    Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P
    Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of ovarian cyst formation in women taking ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms.
    Friedman AJ; Wheeler JM
    J Reprod Med; 1991 Apr; 36(4 Suppl):345-9. PubMed ID: 2046084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of a new estrogen-progestational combination at low doses in gynecologic therapy].
    Seassaro E
    Quad Clin Ostet Ginecol; 1969 Jun; 24(6):385-97. PubMed ID: 5398761
    [No Abstract]   [Full Text] [Related]  

  • 12. [Provisional results of a clinical study of sequential and combination therapy with oral contraceptives].
    Arnold M; Angst-Horridge A; Burckhardt-Tamm E; Cloeren S; Mall-Haefeli M; Richter RH; Streit-Pfenniger M; Wyss H
    Gynaecologia; 1968; 165(2):218-20. PubMed ID: 4178566
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ethynodiol diacetate with ethinyl estradiol on the mammary glands of rhesus monkeys: a preliminary report.
    Drill VA; Golway PL
    J Natl Cancer Inst; 1978 May; 60(5):1169-70. PubMed ID: 417188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Steroid contraceptives].
    Matsumoto S
    Horumon To Rinsho; 1972 Jun; 20(6):463-8. PubMed ID: 4673193
    [No Abstract]   [Full Text] [Related]  

  • 15. [The search for new ways with low dose contraceptives. II].
    Tóth F; Gimes R; Horn B; Kerényi T
    Z Arztl Fortbild (Jena); 1972 Oct; 66(20):1021-5. PubMed ID: 4651027
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of oral contraceptives on glucose tolerance.
    Boshell BR; Roddam RF; McAdams GL; Fox OJ
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232
    [No Abstract]   [Full Text] [Related]  

  • 17. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M; Beck P
    Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental treatment of menopausal disorders by an estrogen-progestogen combination with the estrogen dominant or mixed and then a weak estrogen-progestogen combination].
    Dorangeon P
    Rev Fr Gynecol Obstet; 1974 Jan; 69(1):49-54. PubMed ID: 17436492
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of breakthrough bleeding during oral contraceptive therapy.
    Hill GA; Wheeler JM
    J Reprod Med; 1991 Apr; 36(4 Suppl):334-9. PubMed ID: 2046082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Problems of the statistical evaluation of clinical studies on oral contraceptives].
    Richter RH; Angst-Horridge A; Arnold M; Mall-Haefeli M; Roth F; Streit-Pfenniger M; Wyss H
    Arch Gynakol; 1969; 207(1):28-30. PubMed ID: 4184750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.